Olaplex Holdings, INC.: directors' dealings · United States · SEC (Form 4)

About Olaplex Holdings, INC.

OLAPLEX HOLDINGS, INC. (NASDAQ: OLPX) is a United States-based premium haircare company listed on the NASDAQ market. The business built its reputation around a patented, science-led bond-building technology that was introduced in 2014 and first adopted by professional hairstylists before expanding into consumer channels. For investors, OLAPLEX represents a focused branded beauty platform with strong category awareness, premium pricing power relative to mass-market haircare, and a business model that relies heavily on professional endorsement, product innovation, and omnichannel execution. The company operates through three main distribution channels: Professional, Specialty Retail, and Direct-to-Consumer. The Professional channel is strategically important because it anchors the brand within salons and among hairstylists, who are a core source of product advocacy and consumer conversion. Specialty retail extends brand visibility and helps OLAPLEX reach a broader prestige audience, while DTC supports full-brand engagement and higher-margin direct relationships with consumers. This channel mix is central to OLAPLEX’s competitive positioning versus larger beauty conglomerates and smaller niche haircare brands. Founded in 2014, OLAPLEX built its brand around hair-health solutions designed to protect, strengthen, and relink damaged bonds in the hair. Its portfolio spans professional salon treatments, wash-care products, styling products, and at-home maintenance routines. The company markets itself as a science-enabled and innovation-driven haircare brand, with messaging centered on healthy hair rather than cosmetic styling alone. That positioning has helped OLAPLEX establish a differentiated presence in prestige haircare, a segment supported by consumer trading-up behavior and recurring replenishment demand. Geographically, OLAPLEX is rooted in the United States, its home market, while also pursuing international growth, particularly in Europe and other key markets. The company’s primary executive office is in New York, although its brand heritage is closely linked to Santa Barbara, California, where the chemistry behind the brand was originally developed. OLAPLEX’s manufacturing footprint is also relevant, with finished products produced in the United States and Europe, including a meaningful portion made in California. Recent developments are material for the equity story. OLAPLEX reported first-quarter 2026 results on May 11, 2026, following its full-year 2025 results in March 2026. In 2025, management continued its multi-year transformation, refreshed the board, and announced the acquisition of biotech company Purvala to support future product innovation. Most notably, in March 2026 the company announced a definitive agreement to be acquired by Henkel AG & Co. KGaA in an all-cash transaction; if completed, OLAPLEX would no longer remain listed on the NASDAQ. That transaction is a major strategic event and frames the near-term outlook for shareholders.